BRANFORD, Conn., Aug. 04, 2016 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three and six months ended June 30, 2016.
Net sales from continuing operations increased 18% to $5.5 million for the second quarter of 2016, from $4.7 million for the second quarter of 2015.
The Company recorded a net loss applicable to common stockholders for the second quarter of 2016 of $2.1 million, or $0.08 per share, compared with a net loss applicable to common stockholders for the second quarter of 2015 of $2.3 million, or $0.09 per share.
Net sales from continuing operations increased 18% to $5.5 million for the second quarter of 2016, from $4.7 million for the second quarter of 2015.
The Company recorded a net loss applicable to common stockholders for the second quarter of 2016 of $2.1 million, or $0.08 per share, compared with a net loss applicable to common stockholders for the second quarter of 2015 of $2.3 million, or $0.09 per share.
